Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 20Neoplasms 19Lung Neoplasms 11Carcinoma, Non-Small-Cell Lung 8Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Prostatic Neoplasms 5Pancreatic Neoplasms 5Melanoma 5Carcinoma, Hepatocellular 5Brain Neoplasms 5Skin Neoplasms 4Ovarian Neoplasms 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Triple Negative Breast Neoplasms 3Neoplasm Metastasis 3Myeloproliferative Disorders 3Kidney Neoplasms 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3Uveal Melanoma 2Recurrence 2Neoplasm, Residual 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell 2Lung Diseases 2Glioma 2

Interventions

Gemcitabine 3Cisplatin 3toripalimab 2Radiotherapy, Intensity-Modulated 2spartalizumab 1atezolizumab 1Surveys and Questionnaires 1Phantoms, Imaging 1Observation 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Disulfides 1Carboplatin 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Neoplasms × Blood Specimen Collection × 90 days × Clear all
NCT06682442 2026-05-01

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

University of California, San Francisco

Phase NA Recruiting
66 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡